Latest Research

Microfluidics can help to determine the antioxidant capacity of RBCs to reduce the risk of anaemia during chemotherapy

Abstract

“Oxidative stress is one of the key factors that leads to red blood cells (RBCs) aging, and impairs their biomechanics and oxygen delivery. It occurs during numerous pathological processes and causes anaemia, one of the most frequent side effects of cancer chemotherapy. Here, we used microfluidics to simulate the microcirculation of RBCs under oxidative stress induced by tert-Butyl hydroperoxide. Oxidative stress was expected to make RBCs more rigid, which would lead to decrease their transit velocity in microfluidic channels. However, single-cell tracking combined with cytological and AFM studies reveals cell heterogeneity, which increases with the level of oxidative stress. The data indicates that the built-in antioxidant defence system has a limit exceeding which haemoglobin oxidation, membrane, and cytoskeleton transformation occurs. It leads to cell swelling, increased stiffness and adhesion, resulting in a decrease in the transit velocity in microcapillaries. However, even at high levels of oxidative stress, there are persistent cells in the population with an undisturbed biophysical phenotype that retain the ability to move in microcapillaries. Developed microfluidic analysis can be used to determine RBCs’ antioxidant capacity for the minimization of anaemia during cancer chemotherapy.

 

a Schematic view of the device; b an image of a single microchannel with control RBCs; c 1.5 mM tBuOOH treatment can lead to microchannel’s occlusion. t1 and t2 marks indicate the capturing points for determining cells’ transit time in microchannels.” Reproduced under Creative Commons Attribution 4.0 International License from Besedina, N.A., Skverchinskaya, E.A., Shmakov, S.V. et al. Persistent red blood cells retain their ability to move in microcapillaries under high levels of oxidative stress. Commun Biol 5, 659 (2022).


Figures and the abstract are reproduced from
Besedina, N.A., Skverchinskaya, E.A., Shmakov, S.V. et al. Persistent red blood cells retain their ability to move in microcapillaries under high levels of oxidative stress. Commun Biol 5, 659 (2022). https://doi.org/10.1038/s42003-022-03620-5

Read the original article: Microfluidic device for investigation of RBCs transport in microcapillaries

Pouriya Bayat

Published by
Pouriya Bayat

Recent Posts

Microfluidics Reveal Iron Deficiency Leads to More Deformable Red Blood Cells

Red blood cell (RBC) deformability, the ability of RBCs to squeeze through tiny capillaries, is…

June 27, 2025

A Reconfigurable Microfluidic Platform for Sample-Efficient Antibody Fc Biomarker Discovery

Precise diagnosis of infectious diseases is often hindered by a lack of accessible biomarkers that…

June 17, 2025

Ultrafast and Scalable CAR-T Manufacturing Using Microfluidics

Chimeric antigen receptor T-cell (CAR-T) therapy has reshaped the treatment landscape for hematologic cancers, but…

June 12, 2025

Compartmentalized perfusion enables precise control of microenvironments in cardiac microfluidics

In complex tissue environments, cells constantly interact with dynamic chemical signals, many of which are…

May 27, 2025

Microfluidic model shows α‑Synuclein spreads backward along axons

Lewy bodies -intracellular aggregates rich in α‑Synuclein (αSyn)- appear in a stereotyped pattern as Parkinson’s…

May 3, 2025

AI-Enabled Microfluidic Device for Rapid CD4+ T Cell Counting in Whole Blood

CD4+ T cell counts are essential for diagnosing and monitoring diseases like HIV, cancers, and…

April 7, 2025